Skip to main content

Allergic Bronchopulmonary Aspergillosis

An Evolving Challenge in Asthma

  • Chapter
Bronchial Asthma

Part of the book series: Current Clinical Practice ((CCP))

  • 1130 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aron Y, Bienvenu T, Hubert D, et al. HLA-DR polymorphism in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1999; 104(4 Pt 1): 891–892.

    Article  PubMed  CAS  Google Scholar 

  2. Mastella G, Rainisio M, Harms HK, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2000; 16: 464–471.

    Article  PubMed  CAS  Google Scholar 

  3. Hinson KF, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis: a review and a report of eight new cases. Thorax 1952; 7: 317–333.

    PubMed  CAS  Google Scholar 

  4. Wark PA, Saltos N, Simpson J, et al. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J 2000; 16: 1095–1101.

    Article  PubMed  CAS  Google Scholar 

  5. Skov M, Poulsen LK, Koch C. Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis. Pediatr Pulmonol 1999; 27: 74–79.

    Article  PubMed  CAS  Google Scholar 

  6. Grunig G, Corry DB, Leach MW, et al. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med 1997; 185: 1089–1099.

    Article  PubMed  CAS  Google Scholar 

  7. Kheradmand F, Kiss A, Xu J, et al. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J Immunol 2002; 169: 5904–5911.

    PubMed  CAS  Google Scholar 

  8. Khan S, McClellan JS, Knutsen AP. Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis. Int Arch Allergy Immunol 2000; 123: 319–326.

    Article  PubMed  CAS  Google Scholar 

  9. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 696–709.

    Article  PubMed  CAS  Google Scholar 

  10. Chung Y, Kraut JR, Stone AM, Valaitis J. Disseminated aspergillosis in a patient with cystic fibrosis and allergic bronchopulmonary aspergillosis. Pediatr Pulmonol 1994; 17: 131–134.

    Article  PubMed  CAS  Google Scholar 

  11. Bodey GP, Glann AS. Central nervous system aspergillosis following corticosteroidal therapy for allergic bronchopulmonary aspergillosis. Chest 1993; 103: 299–301.

    Article  PubMed  CAS  Google Scholar 

  12. Reiff DB, Wells AU, Carr DH, Cole PJ, Hansell DM. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. Am J Roentgenol 1995; 165: 261–267.

    CAS  Google Scholar 

  13. Saraceno JL, Phelps DT, Ferro TJ, Futerfas R, Schwartz DB. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 1997; 112: 541–548.

    Article  PubMed  CAS  Google Scholar 

  14. Safirstein BH, D’Souza MF, Simon G, Tai EH, Pepys J. Five-year follow-up of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1973; 108: 450–459.

    PubMed  CAS  Google Scholar 

  15. Rosenberg M, Mintzer R, Aaronson DW, Patterson R. Allergic bronchopulmonary aspergillosis in three patients with normal chest x-ray films. Chest 1977; 72: 597–600.

    Article  PubMed  CAS  Google Scholar 

  16. Kumar R, Gaur SN. Prevalence of allergic bronchopulmonary aspergillosis in patients with bronchial asthma. Asian Pac J Allergy Immunol 2000; 18: 181–185.

    PubMed  CAS  Google Scholar 

  17. O’Connor TM, O’Donnell A, Hurley M, Bredin CP. Allergic bronchopulmonary aspergillosis: a rare cause of pleural effusion. Respirology 2001; 6: 361–363.

    Article  PubMed  CAS  Google Scholar 

  18. Panchal N, Bhagat R, Pant C, Shah A. Allergic bronchopulmonary aspergillosis: the spectrum of computed tomography appearances. Respir Med 1997; 91: 213–219.

    Article  PubMed  CAS  Google Scholar 

  19. Munro NC, Han LY, Currie DC, Strickland B, Cole PJ. Radiological evidence of progression of bronchiectasis. Respir Med 1992; 86: 397–401.

    Article  PubMed  CAS  Google Scholar 

  20. Rosenberg M, Patterson R, Roberts M. Immunologic responses to therapy in allergic bronchopulmonary aspergillosis: serum IgE value as an indicator and predictor of disease activity. J Pediatr 1977; 91: 914–917.

    Article  PubMed  CAS  Google Scholar 

  21. Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000; 162(Pt 1): 1277–128.

    PubMed  CAS  Google Scholar 

  22. Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 1999; 115: 364–370.

    Article  PubMed  CAS  Google Scholar 

  23. Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med 1982; 96: 286–291.

    PubMed  CAS  Google Scholar 

  24. Kumar R, Singh P, Arora R, Gaur SN. Effect of itraconazole therapy in allergic bronchopulmonary aspergillosis. Saudi Med J 2003; 24: 546–547.

    PubMed  Google Scholar 

  25. Kiely JL, Spense L, Henry M, et al. Chest radiographic staging in allergic bronchopulmonary aspergillosis: relationship with immunological findings. Eur Respir J 1998; 12: 453–456.

    Article  PubMed  CAS  Google Scholar 

  26. Mroueh S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 1994; 105: 32–36.

    Article  PubMed  CAS  Google Scholar 

  27. Marchand E, Verellen-Dumoulin C, Mairesse M, et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001; 119: 762–767.

    Article  PubMed  CAS  Google Scholar 

  28. Cordier J. Eosinophilic pneumonias. In M. I. A. K. Schwarz, T. E. (ed.). Intersitial lung disease, 4th ed. B C Decker, Inc., Hamilton, Ontario, 2003, pp. 657–700.

    Google Scholar 

  29. Seaton A, Seaton RA, Wightman AJ. Management of allergic bronchopulmonary aspergillosis without maintenance oral corticosteroids: a fifteen-year follow-up. QJM 1994; 87: 529–537.

    PubMed  CAS  Google Scholar 

  30. Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis. Report to the Research Committee of the British Thoracic Association. Br J Dis Chest 1979; 73: 349–356.

    Article  Google Scholar 

  31. Henderson AH, Pearson JE. Treatment of bronchopulmonary aspergillosis with observations on the use of natamycin. Thorax 1968; 23: 519–523.

    PubMed  CAS  Google Scholar 

  32. Currie DC, Lueck C, Milburn HJ, et al. Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis. Thorax 1990; 45: 447–450.

    PubMed  CAS  Google Scholar 

  33. Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000; 342: 756–762.

    Article  PubMed  CAS  Google Scholar 

  34. Salez F, Brichet A, Desurmont S, et al. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 1999; 116: 1665–1668.

    Article  PubMed  CAS  Google Scholar 

  35. Wark PA, Hensley MJ, Saltos N, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111: 952–957.

    Article  PubMed  CAS  Google Scholar 

  36. Murphy M, Bernard EM, Ishimaru T, Armstrong T. Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 1997; 41: 696–698.

    PubMed  CAS  Google Scholar 

  37. Morrissey BM, Evans SJ. Severe bronchiectasis. Clin Rev Allergy Immunol 2003; 25: 233–247.

    Article  PubMed  Google Scholar 

  38. Sancho JM, Ribera JM, Rosell A, Munoz C, Feliu E. Unusual invasive bronchial aspergillosis in a patient with acute lymphoblastic leukemia. Haematologica 1997; 82: 701–702.

    PubMed  CAS  Google Scholar 

  39. Pinson P, Van der Straeten M. Fibrotic stage of allergic bronchopulmonary candidiasis. Chest 1991; 100: 565–567.

    Article  PubMed  CAS  Google Scholar 

  40. Saini SK, Boas SR, Jerath A, Roberts M, Greenberger PA. Allergic bronchopulmonary mycosis to Fusarium vasinfectum in a child. Ann Allergy Asthma Immunol 1998; 80: 377–380.

    Article  PubMed  CAS  Google Scholar 

  41. Backman KS, Roberts M, Patterson R. Allergic bronchopulmonary mycosis caused by Fusarium vasinfectum. Am J Respir Crit Care Med 1995; 152(Pt 1): 1379–1381.

    PubMed  CAS  Google Scholar 

  42. Miller MA, Greenberger PA, Amerian R, et al. Allergic bronchopulmonary mycosis caused by Pseudallescheria boydii. Am Rev Respir Dis 1993; 148: 810–812.

    PubMed  CAS  Google Scholar 

  43. Cimon B, Carrere J, Vinatier JF, et al. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000; 19: 53–56.

    Article  PubMed  CAS  Google Scholar 

  44. Shale DJ, Faux JA, Lane DJ. Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax 1987; 42: 26–31.

    Article  PubMed  CAS  Google Scholar 

  45. Fujimori Y, Tada S, Kataoka M, et al. Allergic bronchopulmonary aspergillosis effectively treated with itraconazole. Nihon Kokyuki Gakkai Zasshi 1998; 36: 781–786.

    PubMed  CAS  Google Scholar 

  46. Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977; 86: 405–414.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.

About this chapter

Cite this chapter

Morrissey, B.M., Louie, S. (2006). Allergic Bronchopulmonary Aspergillosis. In: Gershwin, M.E., Albertson, T.E. (eds) Bronchial Asthma. Current Clinical Practice. Humana Press. https://doi.org/10.1385/1-59745-014-6:279

Download citation

  • DOI: https://doi.org/10.1385/1-59745-014-6:279

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-604-7

  • Online ISBN: 978-1-59745-014-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics